Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
China Pharma Holdings ( (CPHI) ) has provided an announcement.
At its annual stockholders’ meeting held on December 30, 2025 for the fiscal year ended December 31, 2024, China Pharma Holdings, Inc. reported that approximately 69.71% of its outstanding common shares were represented, constituting a valid quorum for conducting corporate business. Shareholders elected three independent directors—Gene Michael Bennett, Yingwen Zhang and Baowen Dong—to serve until the next annual meeting, approved an amendment to the Articles of Incorporation authorizing a reverse stock split at a ratio of up to 1-for-20 at the board’s discretion, and adopted Amendment No. 3 to the company’s Amended and Restated 2010 Long-Term Incentive Plan, decisions that collectively reinforce the company’s governance structure, provide flexibility to manage its capital structure, and adjust its long-term equity compensation framework for employees and directors.
The most recent analyst rating on (CPHI) stock is a Hold with a $1.50 price target. To see the full list of analyst forecasts on China Pharma Holdings stock, see the CPHI Stock Forecast page.
Spark’s Take on CPHI Stock
According to Spark, TipRanks’ AI Analyst, CPHI is a Neutral.
The score is primarily weighed down by weak financial performance (large losses, negative margins, and poor cash flow) and bearish technicals (below major moving averages with negative MACD). Corporate events provide some strategic upside via pipeline expansion, but dilution risk and the lack of valuation support due to losses keep the overall score low.
To see Spark’s full report on CPHI stock, click here.
More about China Pharma Holdings
China Pharma Holdings, Inc. is a pharmaceutical company focused on developing, manufacturing and marketing generic and branded drug products for the Chinese healthcare market.
Average Trading Volume: 24,298
Technical Sentiment Signal: Sell
Current Market Cap: $6.28M
For an in-depth examination of CPHI stock, go to TipRanks’ Overview page.